Public Sector Pension Investment Board (PSP Investments)
PCRX icon

Public Sector Pension Investment Board (PSP Investments)’s Pacira BioSciences PCRX Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.43M Sell
135,188
-11,852
-8% -$280K 0.01% 1116
2026
Q1 		$3.32M Sell
147,040
-41,878
-22% -$931K 0.01% 1058
2025
Q4 		$4.89M Sell
188,918
-16,052
-8% -$382K 0.02% 862
2025
Q3 		$5.28M Buy
204,970
+6,303
+3% +$155K 0.02% 765
2025
Q2 		$4.75M Buy
198,667
+10,693
+6% +$270K 0.02% 704
2025
Q1 		$4.67M Buy
187,974
+72,517
+63% +$1.74M 0.02% 739
2024
Q4 		$2.18M Buy
115,457
+17,628
+18% +$310K 0.01% 1002
2024
Q3 		$1.47M Sell
97,829
-4,600
-4% -$78.6K 0.01% 989
2024
Q2 		$2.93M Buy
102,429
+7,243
+8% +$206K 0.02% 676
2024
Q1 		$2.78M Sell
95,186
-1,180
-1% -$36.3K 0.02% 630
2023
Q4 		$3.25M Buy
96,366
+38,996
+68% +$1.14M 0.02% 556
2023
Q3 		$1.76M Sell
57,370
-24,261
-30% -$874K 0.01% 827
2023
Q2 		$3.27M Buy
81,631
+935
+1% +$38.7K 0.02% 638
2023
Q1 		$3.29M Sell
80,696
-2,777
-3% -$110K 0.02% 633
2022
Q4 		$3.22M Sell
83,473
-638
-0.8% -$31K 0.02% 648
2022
Q3 		$4.47M Hold
84,111
– – 0.04% 403
2022
Q2 		$4.9M Buy
84,111
+971
+1% +$63.6K 0.04% 350
2022
Q1 		$6.34M Sell
83,140
-7,590
-8% -$506K 0.04% 380
2021
Q4 		$5.46M Buy
90,730
+770
+0.9% +$42.5K 0.03% 526
2021
Q3 		$5.04M Hold
89,960
– – 0.03% 553
2021
Q2 		$5.46M Buy
89,960
+390
+0.4% +$24.7K 0.03% 496
2021
Q1 		$6.28M Sell
89,570
-6,530
-7% -$466K 0.04% 401
2020
Q4 		$5.75M Buy
96,100
+1,470
+2% +$86.1K 0.04% 401
2020
Q3 		$5.69M Buy
94,630
+430
+0.5% +$25K 0.05% 368
2020
Q2 		$4.94M Buy
94,200
+700
+0.7% +$29.3K 0.05% 379
2020
Q1 		$3.13M Hold
93,500
– – 0.04% 442
2019
Q4 		$4.24M Sell
93,500
-12,500
-12% -$531K 0.03% 692
2019
Q3 		$4.04M Buy
+106,000
New +$4.23M 0.03% 665

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s PCRX Position: Q2 2026 in Review

Public Sector Pension Investment Board (PSP Investments) reduced its Pacira BioSciences (PCRX) stake by 8.1% in Q2 2026, selling an estimated $280K and leaving 135,188 shares worth $3.43M. The position accounts for 0.01% of the portfolio, ranked #1116.

Public Sector Pension Investment Board (PSP Investments) first reported a position in PCRX in Q3 2019 and has held it in 28 quarters since. The position peaked at $6.34M in Q1 2022. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 135,188 shares of Pacira BioSciences worth $3.43M as of Q2 2026.
  • Public Sector Pension Investment Board (PSP Investments) sold 11,852 Pacira BioSciences shares in Q2 2026, an estimated $280K.
  • Pacira BioSciences made up 0.01% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q2 2026, its #1116 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Pacira BioSciences in Q3 2019 and has held it in 28 quarters since.
  • Public Sector Pension Investment Board (PSP Investments)'s Pacira BioSciences position peaked at $6.34M in Q1 2022.
  • 183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.